Tuberculosis remains one of the deadliest infectious diseases worldwide, with drug-resistant strains posing a significant ...

PHAXIAM Therapeutics (Euronext: PHXM - FR0011471135), a biopharmaceutical company (“PHAXIAM” or “the Company”) developing innovative ...

Zaynich could play a key role in treating patients suffering from complicated urinary tract infections caused by ...

Bacteriophage MarketThe global bacteriophage market, valued at USD 45.07 million in 2023, is projected to reach USD 68 million by 2033, growing at a CAGR of 4.2% over the forecast period. The ...

For years, Radha Lama bought antibiotics in bulk at a clinic near her home in Kathmandu, Nepal. She took the pills whenever she had a stomachache or headache, without talking to a doctor or nurse, ...

Osta Therapeutics, a biotechnology company developing smart drugs to fight antibiotic resistance, today announced the appointments of Dr. Gilles Courtemanche as Senior Scientific Advisor and Dr.

Antibiotic resistance can develop to new antibiotics even before they reach the market, undermining their future ...

The endTB trial is one of four recent randomized controlled trials testing new, shorter, and less toxic treatment regimens ...

Researchers from Indiana University (IU) and Makerere University in Uganda suggest that high uric acid concentrations ...

At Texas A&M University, one research lab is changing the game of droplet microfluidics, a technique that involves conducting ...

Scientists have discovered three powerful new drug regimens that offer more effective treatment for tuberculosis—bringing ...

Antibiotics are often thought of as an easy cure to bacterial infections, but they could be fueling an urgent public health ...